Opportunities for Organ Donor Intervention Research: Saving Lives by Improving the Quality and Quantity of Organs for Transplantation

The National Academic Press, October 10, 2017
By I. Glenn Cohen (Faculty Director) and members of the Committee on Issues in Organ Donor Intervention Research

The organ donation and transplantation system strives to honor the gift of donated organs by fully using those organs to save and improve the quality of the lives of their recipients. While most related research to date has focused on improving transplantation processes and health outcomes for recipients,…

Read More

Pre-order now and get 30% off! Specimen Science: Ethics and Policy Implications

MIT Press, September 2017
Edited by Holly Fernandez Lynch (Executive Director), Barbara E. Bierer, I. Glenn Cohen (Faculty Director), and Suzanne M. Rivera

Pre-order through MIT Press and receive 30% off using discount code MSPECIMEN30: Order now! This edited volume stems from a conference…

Read More

ORDER NOW & GET 20% OFF! Law, Religion, and Health in the United States

Cambridge University Press, July 2017
Holly Fernandez Lynch (Executive Director), I. Glenn Cohen (Faculty Director), and Elizabeth Sepper

About the Book: While the law can create conflict between religion and health, it can also facilitate religious accommodation and protection of conscience. Finding this balance is critical to addressing the most pressing questions at the intersection of law, religion,…

Read More

Innovative Contracting for Pharmaceuticals and Medicaid’s Best-Price Rule

Journal of Health Politics, Policy and Law, September 28, 2017
Rachel E. Sachs (Academic Fellow Alumna), Nicholas Bagley, and Darius N. Lakdawalla

From the paper: In recent years, drug manufacturers and private payers have expressed interest in novel pricing models that more closely link a drug’s price to its value. Indication-based pricing, outcome-based pricing, drug licenses, and drug mortgages have…

Read More

Mobile Health Innovation and Interagency Coordination

Annals of Health Law, Vol. 26, Issue 22
Rachel E. Sachs (Academic Fellow Alumna)

From the paper: An app that can tell when a phone’s owner is having a seizure.1 A device that transforms a phone into a mobile EKG machine.2 An app that helps patients track their moles over time—and maybe alerts them when they should see a doctor.3 Just…

Read More

TEDxCambridge, Featuring Faculty Director I. Glenn Cohen: October 12, 2017

TEDxCambridge, October 12, 2017, Boston Opera House
I. Glenn Cohen (Faculty Director)

Join us on October 12, 2017 at the Boston Opera House! TEDxCambridge curates one of the largest TEDx conferences in the world featuring 2,500 guests, six distinguished speakers, one exceptional performance, and a technology exhibition. …

Read More

Paternalism, reasonableness, and neutrality: a response to commentators

Journal of Medical Ethics, September 2017, Vol. 43 No. 9
Frances Kamm (former Senior Fellow)

From the article (from the commentary on Frances Kamm's earlier article, "Advanced Care and End of Life Care: Some Cautionary Suggestions."

Read More

Your Money or Your Patient’s Life? Ransomware and Electronic Health Records

Annals of Internal Medicine, September 19, 2017
By I. Glenn Cohen (Faculty Director), Sharona Hoffman, and Eli Y. Adashi

The mugger's demand “Your money or your life” is a familiar one. However, in an era of vast hospital computer networks and electronic health records, a novel risk to worry about is, “Your money or your patient's life.” This threat, known…

Read More

PFC Spotlight: Student Fellow Alumna Sara Abiola

Petrie-Flom Center, September 7, 2017

Sara Abiola, PhD, JD, was a Student Fellow during the 2006-2007 academic year, while a second-year law student and first-year health policy doctoral candidate. As part of the…

Read More

Influence, integrity, and the FDA: An ethical framework

Science, Sep 1, 2017: Vol. 357, Issue 6354, pp. 876-877.
Spencer Phillips Hey, I. Glenn Cohen (Faculty Director), Eli Y. Adashi, & Aaron S. Kesselheim

Summary: Among the core missions of the U.S. Food and Drug Administration (FDA) are protecting public health by assuring the safety and efficacy of drugs, biologics, and medical devices and advancing public health by…

Read More

New Serious Illness Program Design and Implementation Framework

Coalition to Transform Advanced Care (C-TAC), August 17, 2017
Khue Nguyen, Theresa Schmidt, Robin Whitney, Gary Bacher, Janice Bell, Sibel Ozcelik (Lead Authors)

As part of the Project on Advanced Care and Health Policy, the Petrie-Flom Center hosted two convenings on Critical…

Read More

Questions About The FDA’s New Framework For Digital Health

Health Affairs Blog, August 16, 2017
Nathan G. Cortez, Nicolas Terry, and I. Glenn Cohen (Faculty Director)

From the article: In June 2017, the new Food and Drug Administration (FDA) commissioner Scott Gottlieb pre-announced his agency’s Digital Health Innovation Action Plan that indicates notable shifts in the agency’s approach to digital…

Read More

Administering Health Innovation

Cardozo Law Review, Forthcoming 2018
Rachel E. Sachs (Academic Fellow Alumna)

Abstract Scholars and policymakers have recently begun to focus on the role federal agencies charged with health-related missions can play in the development of innovative health technologies and promotion of access to those technologies. Appreciating the expertise of agencies…

Read More

Artificial Wombs and Abortion Rights

The Hastings Center Report, July 27, 2017
I. Glenn Cohen (Faculty Director)

Abstract: In a study published in late April in Nature Communications, the authors were able to sustain 105- to 115-day-old premature lamb fetuses—whose level of development was comparable to that of a twenty-three-week-old…

Read More

Public Participation in Drafting of the 21st Century Cures Act

The Journal of Law, Medicine & Ethics, July 14, 2017
Thomas J. Hwang, Rachel E. Sachs (Academic Fellow Alumna), Aaron S. Kesselheim

Abstract The 21st Century Cures Act is a major act of legislation that contains numerous changes to drug and device regulation. The House of Representatives passed the Act after considerable interest group lobbying, but the bill and the key changes…

Read More

Panel: Weighing the Risks of Randomized Controlled Trials and Alternatives

The New York Academy of Sciences, June 21, 2017
Panel featuring Holly Fernandez Lynch (Executive Director), Amrit Ray, Matthew Rotelli, Steve Usdin, and Robert Walker

On June 21, 2017, Executive Director Holly Fernandez Lynch participated in a panel discussion on "Weighing the Risks of Randomized Controlled Trials and Alternatives," which was part of the…

Read More

At Drug Hearing, Senators Discuss Meanings of Price and Value - and Debate Health Reform

Health Affairs Blog, June 20, 2017
Rachel E. Sachs (Academic Fellow Alumna)

From the article by Rachel E. Sachs, (Academic Fellow Alumna): On Tuesday, June 13, the Senate Health, Education, Labor, & Pensions…

Read More

Book Review: I Contain Multitudes - The Microbes Within us and a Grander View of Life

Journal of Law and the Biosciences, June 2017
Rachel E. Sachs (Academic Fellow Alumna)

From the review by Rachel E. Sachs: Ed Yong's I Contain Multitudes: The Microbes Within us and a Grander View of Life is…

Read More

ERISA: A Bipartisan Problem For The ACA And The AHCA

Health Affairs Blog, June 2, 2017
Abbe R. Gluck, Allison K. Hoffman (Academic Fellow Alumna), and Peter D. Jacobson

From the post: The Supreme Court has once again been called on to mediate the boundaries of a far-reaching, infamously complex, federal employee benefits law. And once again this law may have an important and unanticipated effect on health care.

Read More

From the Technical to the Personal: Teaching and Learning Health Insurance Regulation and Reform

Saint Louis University Law Journal, Vol. 61, no. 411
Allison K. Hoffman (Academic Fellow Alumna), Whitney A. Brown, and Lindsay Cutler

From the article: In the Fall of 2016, I taught Health Law and Policy for the fourth consecutive semester. In this repeat loop, one thing has become increasingly clear: the aspect of this survey course that I work with most closely as a scholar—the regulation…

Read More